Medicare Enrolled
Dr. Richards Afonja, MD
Hematology & Oncology · Clifton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Afonja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Afonja?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Afonja
Dr. Richards Afonja is a hematology & oncology specialist in Clifton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Afonja performed 5,174 Medicare services across 1,062 unique beneficiaries.
Between the years covered by Open Payments, Dr. Afonja received a total of $7,746 from 53 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Afonja is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 36% volume in NJ
$7,746 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,174
Medicare services
Top 36% in NJ for hematology & oncology
1,062
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 947 | $2 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
715 | $70 | $166 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
450 | $22 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $101 | $251 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
429 | $8 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
311 | $12 | $52 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
286 | $58 | $172 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
280 | $1 | $11 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
247 | $101 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
229 | $68 | $125 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
203 | $8 | $19 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
161 | $1 | $10 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
136 | $0 | $5 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
117 | $19 | $61 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
37 | $95 | $392 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
36 | $41 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $132 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $34 | $146 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
23 | $16 | $52 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
20 | $47 | $130 |
| Flow cytometry, 16 or more markers A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties. |
19 | $71 | $225 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
16 | $65 | $200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
14 | $18 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.2% high complexity
30.8% medium
56.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,746
Total received (2018-2024)
Avg $1,107/year across 7 years
Top 32% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,624 (72.6%)
Other
Charitable contributions, space rental, and other categories
$1,345 (17.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$777 (10.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,573
2023
$1,175
2022
$1,015
2021
$1,308
2020
$392
2019
$1,721
2018
$561
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$297
PFIZER INC.
$212
E.R. Squibb & Sons, L.L.C.
$195
Novartis Pharmaceuticals Corporation
$86
AstraZeneca Pharmaceuticals LP
$73
Incyte Corporation
$72
Astellas Pharma US Inc
$65
Celgene Corporation
$62
Exelixis Inc.
$47
Lilly USA, LLC
$47
ABBVIE INC.
$41
PharmaEssentia USA Corporation
$37
Mirati Therapeutics, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$33
Merck Sharp & Dohme LLC
$32
Daiichi Sankyo Inc.
$32
Gilead Sciences, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$26
Emmaus Medical, Inc.
$26
Karyopharm Therapeutics Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
SOBI, INC
$19
Blueprint Medicines Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
Stemline Therapeutics Inc.
$14
Top 3 companies account for 44.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,747
Janssen Biotech, Inc.
$677
AstraZeneca Pharmaceuticals LP
$645
PFIZER INC.
$554
E.R. Squibb & Sons, L.L.C.
$347
Incyte Corporation
$311
Boehringer Ingelheim Pharmaceuticals, Inc.
$311
Celgene Corporation
$304
Daiichi Sankyo Inc.
$218
Alexion Pharmaceuticals, Inc.
$204
Merck Sharp & Dohme Corporation
$181
Octapharma USA, Inc.
$171
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Amgen Inc.
$161
Bayer HealthCare Pharmaceuticals Inc.
$156
EISAI INC.
$129
AbbVie, Inc.
$91
Eisai Inc.
$89
Mirati Therapeutics, Inc.
$88
Merck Sharp & Dohme LLC
$83
Genentech USA, Inc.
$73
Gilead Sciences, Inc.
$72
Rigel Pharmaceuticals, Inc.
$71
GE HEALTHCARE
$67
Astellas Pharma US Inc
$65
Lilly USA, LLC
$62
Exelixis Inc.
$62
Puma Biotechnology, Inc.
$61
Emmaus Medical, Inc.
$49
CTI BioPharma Corp.
$43
ABBVIE INC.
$41
PharmaEssentia USA Corporation
$37
AVEO Pharmaceuticals, Inc.
$33
PUMA BIOTECHNOLOGY, INC.
$33
Blueprint Medicines Corporation
$32
Pharmacyclics LLC, An AbbVie Company
$30
JAZZ PHARMACEUTICALS INC.
$26
Karyopharm Therapeutics Inc.
$21
Spectrum Pharmaceuticals Inc.
$20
SOBI, INC
$19
Agios Pharmaceuticals, Inc.
$17
Pharmacosmos Therapeutics Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
ARRAY BIOPHARMA INC
$15
MorphoSys, US Inc.
$15
AbbVie Inc.
$15
Advanced Accelerator Applications
$15
Global Blood Therapeutics, Inc.
$14
Stemline Therapeutics Inc.
$14
Dova Pharmaceuticals
$12
AMAG Pharmaceuticals, Inc.
$11
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AYVAKIT · BALVERSA · BESREMI · BOSULIF · BRAFTOVI · BREZTRI · CABOMETYX · CALQUENCE · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIQUIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FARXIGA · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JARDIANCE · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LOKELMA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nerlynx · Nplate · Nubeqa · OCTAPLAS · OPDIVO · OXBRYTA · Orserdu · PEMAZYRE · PIQRAY · PROMACTA · PYRUKYND · Pomalyst · REBLOZYL · RETEVMO · ROLVEDON · RYDAPT · Revlimid · SCEMBLIX · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Tavalisse · Turalio · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · Vyloy · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XPOVIO · Xofigo · Xofluza · Xtandi · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
677
Per 100K population
130.6
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Afonja is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Afonja experienced with injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg?
Based on Medicare claims data, Dr. Afonja performed 947 injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Afonja receive payments from pharmaceutical companies?
Yes. Dr. Afonja received a total of $7,746 from 53 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Afonja's costs compare to other hematology & oncology specialists in Clifton?
Dr. Afonja's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Afonja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Clifton
Browse hematology & oncology specialists in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology